Serial changes in liquid biopsy-derived variant allele frequency predict immune checkpoint inhibitor responsiveness in the pan-cancer setting.
- DOI
- 10.1080/2162402x.2022.2052410
- Published
- 2022
- Container
- Oncoimmunology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1080/2162402x.2022.2052410,
title = {Serial changes in liquid biopsy-derived variant allele frequency predict immune checkpoint inhibitor responsiveness in the pan-cancer setting.},
author = {Kato S and Li B and Adashek JJ and Cha SW and Bianchi-Frias D and Qian D and Kim L and So TW and Mitchell M and Kamei N and Hoiness R and Hoo J and Gray PN and Iyama T and Kashiwagi M and Lu HM and Kurzrock R},
year = {2022},
journal = {Oncoimmunology},
doi = {10.1080/2162402x.2022.2052410},
url = {https://doi.org/10.1080/2162402x.2022.2052410}
}RIS
TY - JOUR TI - Serial changes in liquid biopsy-derived variant allele frequency predict immune checkpoint inhibitor responsiveness in the pan-cancer setting. AU - Kato S AU - Li B AU - Adashek JJ AU - Cha SW AU - Bianchi-Frias D AU - Qian D AU - Kim L AU - So TW AU - Mitchell M AU - Kamei N AU - Hoiness R AU - Hoo J AU - Gray PN AU - Iyama T AU - Kashiwagi M AU - Lu HM AU - Kurzrock R PY - 2022 JO - Oncoimmunology DO - 10.1080/2162402x.2022.2052410 UR - https://doi.org/10.1080/2162402x.2022.2052410 ER -
APA
S, K., B, L., JJ, A., SW, C., D, B., D, Q., L, K., TW, S., M, M., N, K., R, H., J, H., PN, G., T, I., M, K., HM, L., & R, K. (2022). Serial changes in liquid biopsy-derived variant allele frequency predict immune checkpoint inhibitor responsiveness in the pan-cancer setting.. Oncoimmunology. https://doi.org/10.1080/2162402x.2022.2052410
Source records
- pubmed · retrieved 2026-09-26T17:37:49.056Z